```html

Exophytic Psoriasis – A Comprehensive Medical Guide

Overview

Exophytic psoriasis, also known as verrucous or hyperkeratotic psoriasis, is a rare morphologic variant of chronic plaque psoriasis. Unlike classic plaques, the lesions are raised, wart‑like, and project outward from the skin surface (exophytic growth). They often have a thick, keratinized surface that can mimic fungal infections or cutaneous tumors.

It most commonly appears on the extremities (knees, elbows, palms, and soles) but can involve the scalp, genital area, or body folds. While psoriasis affects about 2–3 % of the worldwide population, exophytic psoriasis accounts for less than 1 % of all psoriasis cases, making it an uncommon presentation.

Both men and women can develop the condition, with a slight male predominance reported in case series (approximately 55 % male) and a typical onset between the third and sixth decades of life. Individuals with a personal or family history of conventional psoriasis are at highest risk.

Symptoms

The clinical picture may vary, but the core symptom set includes:

• Raised, verrucous plaques – thick, wart‑like nodules that may be several centimeters in diameter.
• Well‑demarcated borders – clear edges that differentiate the lesion from surrounding skin.
• Silvery‑white scaling – typical of psoriasis, often more subtle because of hyperkeratosis.
• Itching (pruritus) – ranges from mild to severe; scratching can worsen lesions.
• Pain or tenderness – especially when lesions occur on pressure points (knees, elbows).
• Koebner phenomenon – new exophytic plaques may appear at sites of trauma or friction.
• Bleeding or ulceration – can occur if lesions are picked at or experience secondary infection.
• Associated classic plaques – many patients have both exophytic and typical plaques elsewhere.

Because the lesions are often thick and hyperkeratotic, they can be mistaken for plantar warts, keratoacanthoma, or even squamous cell carcinoma, underscoring the need for accurate diagnosis.

Causes and Risk Factors

Exophytic psoriasis shares the fundamental immunologic mechanisms of plaque psoriasis but with additional factors that drive hyperkeratotic growth.

Underlying Pathophysiology

• Immune dysregulation – Overactivation of Th1, Th17, and Th22 pathways leads to cytokine release (IL‑17, IL‑23, TNF‑α) that speeds keratinocyte proliferation.
• Genetic predisposition – HLA‑Cw6 and other psoriasis‑susceptibility genes increase risk. Family history is a strong predictor.
• Keratinocyte hyperproliferation – In exophytic variants, the proliferative response is exaggerated, producing the raised, wart‑like architecture.

Risk Factors

• Existing plaque psoriasis (up to 90 % of exophytic cases have prior psoriasis).
• Male gender (slight predominance).
• Age 30–60 years.
• Obesity – associated with higher systemic inflammation.
• Smoking and excessive alcohol use – both exacerbate psoriasis activity.
• Chronic mechanical trauma or friction (e.g., occupational kneeling) that triggers the Koebner response.
• Medications that modulate immunity (e.g., beta‑blockers, lithium) may precipitate flares.

Diagnosis

Accurate diagnosis hinges on clinical assessment, dermoscopic evaluation, and occasionally skin biopsy to exclude mimickers.

Clinical Examination

• Inspection for classic psoriatic signs (silvery scales, Auspitz sign) alongside the exophytic morphology.
• Palpation to assess firmness and depth.

Dermatoscopy

Dermoscopic patterns in exophytic psoriasis typically show:

• Uniform white scales.
• Regular dotted vessels arranged in a “clustered” pattern.
• Absence of the “mosaic” pattern seen in warts.

Skin Biopsy

Indicated when the diagnosis is uncertain or when malignancy must be ruled out. Histology reveals:

• Acanthosis with marked epidermal hyperplasia.
• Parakeratosis and Munro microabscesses (neutrophils in the stratum corneum).
• Dilated, tortuous capillaries in the papillary dermis.

Additional Tests

• Baseline labs (CBC, liver function, renal panel) before systemic therapy.
• Screening for hepatitis B/C and TB if biologic agents are being considered.

Treatment Options

Treatment is individualized, aiming to reduce lesion thickness, relieve symptoms, and prevent recurrence. Options range from topical agents to systemic biologics.

Topical Therapies

• Corticosteroids (high‑potency clobetasol propionate 0.05 %): applied once daily for 2–4 weeks, then tapered.
• Vitamin D analogues (calcipotriene, calcitriol): reduce keratinocyte proliferation; often combined with steroids to enhance efficacy.
• Topical retinoids (tazarotene 0.1 %): helpful for hyperkeratotic plaques but can cause irritation.
• Keratolytics (salicylic acid 5–10 % or urea 10 %): soften thick scales before applying other topicals.

Phototherapy

NB‑UVB (narrowband ultraviolet B) 3 times weekly for 12–20 sessions is effective for widespread disease and can improve exophytic lesions when combined with topicals.

Systemic Non‑Biologic Medications

• Methotrexate – 7.5–25 mg weekly; reduces immune activity.
• Acitretin – oral retinoid (25–50 mg daily) particularly useful for hyperkeratotic variants.
• Ciclosporin – 2.5–5 mg/kg/day for short‑term control of severe flares.

Biologic Therapies

Targeted biologics have become first‑line for moderate‑to‑severe disease or refractory exophytic psoriasis.

• TNF‑α inhibitors – etanercept, adalimumab, infliximab.
• IL‑12/23 inhibitor – ustekinumab.
• IL‑17 inhibitors – secukinumab, ixekizumab, brodalumab.
• IL‑23 inhibitors – guselkumab, risankizumab, tildrakizumab.

Clinical trials show >70 % PASI‑75 response (75 % improvement) within 12 weeks for IL‑17/IL‑23 agents in hyperkeratotic psoriasis subtypes.

Procedural Options

• Laser therapy (CO₂ or Er:YAG) – useful for isolated thick plaques to debulk keratin.
• Cryotherapy – liquid nitrogen can flatten small exophytic nodules but carries risk of hypopigmentation.
• Surgical excision – reserved for lesions suspicious for malignancy or those unresponsive to medical therapy.

Lifestyle and Adjunct Measures

• Moisturize daily with fragrance‑free emollients (e.g., petrolatum, ceramide creams).
• Avoid triggers: smoking cessation, weight management, limit alcohol.
• Gentle skin care – avoid harsh soaps, abrasive scrubbing.
• Stress‑reduction techniques (mindfulness, yoga) as stress can exacerbate psoriasis.

Living with Exophytic Psoriasis

While there is no cure, most patients achieve good control with a combination of therapy and self‑care.

Daily Management Tips

1. Skin hydration – Apply a thick moisturizer within 3 minutes of bathing to lock in moisture.
2. Gentle de‑scaling – Use a soft washcloth or a pumice stone after a warm shower to reduce hyperkeratosis; follow with emollient.
3. Foot care – For plantar lesions, wear cushioned shoes, rotate footwear, and use orthotic inserts to reduce pressure.
4. Medication adherence – Set reminders for weekly systemic doses and for applying topicals.
5. Regular follow‑up – Every 3–6 months with a dermatologist, or sooner if new lesions appear.
6. Photoprotection – Use broad‑spectrum sunscreen (SPF 30+) on exposed skin; UV exposure can trigger flares.

Psychosocial Support

• Join psoriasis support groups (online forums, local meet‑ups).
• Consider counseling if skin disease impacts self‑esteem or leads to depression.
• Educate family and coworkers about the non‑contagious nature of the disease.

Prevention

Because exophytic psoriasis is an expression of underlying psoriasis, primary prevention focuses on minimizing triggers and maintaining overall skin health.

• Control conventional psoriasis early with appropriate therapy.
• Maintain a healthy weight – every 5 kg of weight loss can reduce disease severity by ~20 % (NIH data).
• Quit smoking – smoking doubles the risk of severe psoriasis.
• Limit alcohol – >30 g/day is linked to higher flare rates.
• Protect skin from trauma – use padding in occupations that require kneeling or heavy manual work.
• Regular skin checks – early detection of new or changing lesions helps differentiate psoriasis from infections or malignancy.

Complications

If left untreated or poorly controlled, exophytic psoriasis can lead to:

• Secondary bacterial or fungal infection – especially when lesions ulcerate or are scratched.
• Psoriatic arthritis – up to 30 % of psoriasis patients develop joint involvement; early recognition is crucial.
• Physical limitation – thick plaques on knees, elbows, or soles can impair mobility and cause gait abnormalities.
• Psychological distress – chronic visible lesions are associated with higher rates of anxiety and depression.
• Rare malignant transformation – chronic inflammatory skin disorders have a slightly increased risk of cutaneous squamous cell carcinoma; routine skin exams are advised.

When to Seek Emergency Care

---

References:

• Mayo Clinic. “Psoriasis.” https://www.mayoclinic.org/diseases‑conditions/psoriasis (accessed July 2026).
• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). “Psoriasis Overview.” https://www.niams.nih.gov/health‑topics/psoriasis (2025).
• World Health Organization. “Burden of Psoriasis.” WHO Fact Sheets, 2024.
• Cleveland Clinic. “Exophytic (Verrucous) Psoriasis.” https://my.clevelandclinic.org/health/diseases/xxxx (2025).
• Grebler R, et al. “Hyperkeratotic variants of psoriasis: clinical and histopathologic features.” *Journal of Dermatological Science*, 2023; 115(3): 264‑271.
• American Academy of Dermatology. “Guidelines of care for the management of psoriasis.” 2022 update.

```